Gold prices steady ahead of Fed decision; weekly weakness noted
Healthpeak Properties (NYSE:DOC) President and CEO Scott M. Brinker reported purchasing 2,873 shares of common stock on July 28, 2025, amid a significant 9% decline in share price over the past week. According to InvestingPro analysis, the stock currently appears undervalued compared to its Fair Value.
The shares were bought at a price of $17.40, totaling approximately $49,990. Following the transaction, Brinker directly owns 207,486 shares of Healthpeak Properties. The company maintains a notable 7.07% dividend yield and has sustained dividend payments for 41 consecutive years, demonstrating strong shareholder returns. For deeper insights into Healthpeak’s financial health and additional analysis, investors can access the comprehensive Pro Research Report on InvestingPro.
In other recent news, Healthpeak Properties reported its second-quarter 2025 earnings, showing a mixed financial outcome. The company’s earnings per share (EPS) were $0.05, falling short of the forecasted $0.064, a difference of 21.88%. On the brighter side, Healthpeak’s revenue slightly surpassed expectations, reaching $694.35 million compared to the anticipated $689.32 million. In response to these earnings, Scotiabank (TSX:BNS) downgraded Healthpeak Properties from Sector Outperform to Sector Perform, citing weak leasing performance and increasing laboratory credit risk concerns. Additionally, Scotiabank adjusted its price target for the company to $19.00. KeyBanc, on the other hand, maintained its Sector Weight rating for Healthpeak, highlighting ongoing lab occupancy concerns affecting the healthcare REIT’s performance. These developments reflect the challenges Healthpeak is currently facing in the market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.